相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of Antibiotic Prophylaxis in Anastomotic Leak Prevention during Elective Colorectal Surgery: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Lidia Castagneto-Gissey et al.
ANTIBIOTICS-BASEL (2023)
An update on the safety of long-term vedolizumab use in inflammatory bowel disease
Sailish Honap et al.
EXPERT OPINION ON DRUG SAFETY (2023)
How to reduce the colorectal anastomotic leakage? The MIRACLe protocol experience in a cohort in a single high-volume centre
Rosa Marcellinaro et al.
UPDATES IN SURGERY (2023)
Colectomy risk score predicts pouchitis in patients with ulcerative colitis
Akiyoshi Ikebata et al.
UPDATES IN SURGERY (2022)
Surgery for ulcerative colitis complicated with colorectal cancer: when ileal pouch-anal anastomosis is the right choice
Francesco Tonelli et al.
UPDATES IN SURGERY (2022)
Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues
Mirae Lee et al.
GASTROENTEROLOGY (2021)
AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders
Geoffrey A. Preidis et al.
GASTROENTEROLOGY (2020)
Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis
Gauthier Pellet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Azathioprine Is Useful for Maintaining Long-term Remission Induced by Tacrolimus for the Treatment of Ulcerative Colitis: An Inverse Probability of a Treatment Weighing Analysis
Yu Nishida et al.
INTERNAL MEDICINE (2019)
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
B. E. Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus
L. Vuitton et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study
Andres J. Yarur et al.
GUT (2016)
Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues
K. J. Schmidt et al.
JOURNAL OF CROHNS & COLITIS (2016)
Efficacy and Safety of Tacrolimus Therapy for Active Ulcerative Colitis; A Systematic Review and Meta-analysis
Yuga Komaki et al.
JOURNAL OF CROHNS & COLITIS (2016)
Efficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of Published Placebo-Controlled Trials
Zong Mei Zhang et al.
GUT AND LIVER (2016)
A Comparison of Short- and Long-Term Therapeutic Outcomes of Infliximab- versus Tacrolimus-Based Strategies for Steroid-Refractory Ulcerative Colitis
Katsuya Endo et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
Systematic Review with Network Meta-Analysis: Comparative Efficacy of Biologics in the Treatment of Moderately to Severely Active Ulcerative Colitis
Adrian D. Vickers et al.
PLOS ONE (2016)
Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis
Kentaro Ikeya et al.
DIGESTIVE AND LIVER DISEASE (2015)
Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis
Johannan F. Brandse et al.
GASTROENTEROLOGY (2015)
Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3
Jean-Frederic Colombel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment
Gilles Boschetti et al.
DIGESTIVE AND LIVER DISEASE (2014)
Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients
K. J. Schmidt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity
Simon P. L. Travis et al.
GASTROENTEROLOGY (2013)
52-Week Efficacy of Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis Who Failed Corticosteroids and/or Immunosuppressants
Walter Reinisch et al.
INFLAMMATORY BOWEL DISEASES (2013)
Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients
Jun Miyoshi et al.
Journal of Crohns & Colitis (2013)
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2012)
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
Simon P. L. Travis et al.
GUT (2012)
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
Walter Reinisch et al.
GUT (2011)
Discovery and mechanism of ustekinumab A human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders
Jacqueline M. Benson et al.
MABS (2011)
Risk Factors for Neoplasia in Inflammatory Bowel Disease Patients With Pancolitis
Vivianne Bergeron et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Durable Alteration of the Colonic Microbiota by the Administration of Donor Fecal Flora
Martin J. Grehan et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies
Daniel C. Baumgart et al.
LANCET (2007)
Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease
Siew C. Ng et al.
INFLAMMATORY BOWEL DISEASES (2007)
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease - A long-term follow-up
Daniel C. Baumgart et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis
C Högenauer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Response of refractory colitis to intravenous or oral tacrolimus (FK506)
K Fellermann et al.
INFLAMMATORY BOWEL DISEASES (2002)
Family history as a risk factor for colorectal cancer in inflammatory bowel disease
J Askling et al.
GASTROENTEROLOGY (2001)
分享论文
